삼성서울병원

Ko En

병리과 김현수 교수

진료분야
유방병리, 산부인과병리
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2015.02 경희대학교 대학원 의학과 박사
2010.02 경희대학교 대학원 의학과 석사
2006.02 경희대학교 의과대학 학사

경력

경력
2023.03 ~현재 삼성서울병원 병리과 부교수
2020.03 ~ 2023.02 삼성서울병원 병리과 조교수
2019.09 ~ 2020.02 삼성서울병원 병리과 진료교수
2019.03 ~ 2019.08 삼성서울병원 병리과 진료조교수
2016.03 ~ 2019.02 세브란스병원 병리과 조교수
2015.03 ~ 2016.02 세브란스병원 병리과 임상조교수
2014.05 ~ 2015.02 삼성서울병원 병리과 임상강사
2011.03 ~ 2014.04 공군 항공우주의료원 군의관
2007.03 ~ 2011.02 경희대학교병원 병리과 전공의
2006.03 ~ 2007.02 경희대학교병원 인턴
  • DIAGNOSTICS 2024 10.3390/diagnostics14020160 Dedifferentiated Leiomyosarcoma of the Uterine Corpus with Heterologous Component: Clinicopathological Analysis of Five Consecutive Cases from a Single Institution and Comprehensive Literature Review Kim, S; Bae, H; Kim, HS
    View PubMed
  • BIOMEDICINES 2024 10.3390/biomedicines12010150 Clinicopathological and Molecular Characteristics of IDH-Wildtype Glioblastoma with FGFR3::TACC3 Fusion Bae, H; Lee, B; Hwang, S; Lee, JY; Kim, HS; Suh, YL
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16758 Prediction of Oncotype DX Recurrence Score by Evaluating the Peritumoral Tumor Budding in Early-stage Breast Carcinoma Chu, J; Do, J; Do, SI; Kim, HS
    View PubMed
  • BIOMED PHARMACOTHER 2023 10.1016/j.biopha.2023.115792 Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma Hwang, JR; Cho, YJ; Ryu, JY; Choi, JY; Choi, JJ; Sa, JK; Kim, HS; Lee, JW
    View PubMed
  • J PATHOL CLIN RES 2023 10.1002/cjp2.355 A robust model training strategy using hard negative mining in a weakly labeled dataset for lymphatic invasion in gastric cancer Lee, J; Ahn, S; Kim, HS; An, J; Sim, J
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11113026 Endocervical Adenocarcinoma Showing Microcystic, Elongated, and Fragmented (MELF) Pattern of Stromal Invasion: A Single-Institutional Analysis of 10 Cases with Comprehensive Clinicopathological Analyses and Ki-67 Immunostaining Bae, H; Kim, HS; Farolfi, A
    View PubMed
  • CANCER GENOM PROTEOM 2023 10.21873/cgp.20411 Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival Yoo, H; Kim, HS
    View PubMed
  • IN VIVO 2023 10.21873/invivo.13369 Identification of Predictive Factors for Post-operative Recurrence and Clinical Outcomes of Primary Vulvar Extramammary Paget Disease Do, J; Do, SI; Kim, HS
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16650 Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression Park, S; Cho, Y; Kim, HS
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2023.03.048 The Updated World Health Organization Classification Better Predicts Survivalin Patients With Endocervical Adenocarcinoma (KROG20-07) Cho, WK; Kim, HS; Park, W; Kim, YS; Kang, J; Kim, YB; Kim, YS; Kim, YJ; Kim, KR; Kim, JH; Kwon, SY; Choi, JH; Yoon, M; Kim, NI
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16598 Gastrointestinal Follicular Lymphoma: A Single-institutional Experience of 22 Cases With Emphasis on the Comprehensive Clinicopathological Analysis and Diagnostic Re-classification Oh, CH; Kim, HS; Do, SI; Na, K
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11082269 Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution Koh, HH; Park, E; Kim, HS
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16437 Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors Chu, J; Chung, Y; Chae, SW; Choi, YJ; Kim, HS; DO, SI
    View PubMed
  • IN VIVO 2023 10.21873/invivo.13192 Gastric-type Endocervical Adenocarcinoma: Comprehensive Cytopathological Analysis and Comparison With Usual-type Endocervical Adenocarcinoma Cho, HY; Park, S; Kim, HS
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16397 Clinicopathological Significance and Predictive Value of High Intratumoral Tumor Budding in Patients With Breast Carcinoma Treated With Neoadjuvant Chemotherapy Chu, J; Kim, HS; DO, SI
    View PubMed
  • ANTICANCER RES 2023 10.21873/anticanres.16332 Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing Kim, H; Kim, HS
    View PubMed
  • BIOMATERIALS 2023 10.1016/j.biomaterials.2023.122087 High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing Jun, HR; Kang, HJ; Ju, SH; Kim, JE; Jeon, SY; Ku, BS; Lee, JJ; Kim, M; Kim, MJ; Choi, JJ; Noh, JJ; Kim, HS; Lee, JW; Lee, JK; Lee, DW
    View PubMed
  • DIAGN CYTOPATHOL 2023 10.1002/dc.25111 Cytological features of mesonephric-like adenocarcinoma of the uterine corpus Seo, Y; Park, E; Kim, HS
    View PubMed
  • J CLIN MED 2023 10.3390/jcm12010126 Clinicopathological Characteristics of Primary Pulmonary Hodgkin Lymphoma (PPHL): Two Institutional Experiences with Comprehensive Literature Review of 115 PPHL Cases Jung, HR; Kim, HS; Han, JH; Ko, YH; Choi, YD; Lee, TB
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e71 Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy Cho, WK; Kim, HS; Park, W; Chang, CS; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • CANCER GENOM PROTEOM 2022 10.21873/cgp.20358 Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer Kim, E; Kim, H; Yeo, MK; Kim, CH; Kim, JY; Park, S; Chae, YS; Kim, HS
    View PubMed
  • IN VIVO 2022 10.21873/invivo.13030 Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast Cancer Chu, J; Yeo, MK; Lee, SH; Lee, MY; Chae, SW; Kim, HS; DO, SI
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12102339 Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses Sohn, J; Lee, Y; Kim, HS
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.08.009 Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan Lai, YL; Chang, CS; Chang, KP; Kim, HS; Chen, J; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • ANTICANCER RES 2022 10.21873/anticanres.15945 Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Alpha mong Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer DO, J; Chu, JA; Ahn, J; Bae, GE; Lee, SH; Kim, HS; DO, SI
    View PubMed
  • J COMPUT ASSIST TOMO 2022 10.1097/RCT.0000000000001334 Ovarian Masses in Patients With Breast Cancer Kang, KA; Lee, J; Kim, HS; Park, SY
    View PubMed
  • ANTICANCER RES 2022 10.21873/anticanres.15967 Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors Lee, YRM; Bae, H; Kim, HS
    View PubMed
  • CANCER GENOM PROTEOM 2022 10.21873/cgp.20338 Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases KIM, HG; KIM, H; YEO, MK; WON, KY; KIM, YS; HAN, GH; KIM, HS; NA, K
    View PubMed
  • ANTICANCER RES 2022 10.21873/anticanres.15754 High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma Chung, YM; Kim, S; Kim, HS; Do, SI
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e28 Prognostic value of complete metabolic response on F-18-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer Chung, YS; Kim, Y; Kim, HS; Lee, JY; Kang, WJ; Kim, S; Kim, SW
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12051102 Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics Lee, Y; Na, K; Woo, H; Kim, HS
    View PubMed
  • CELL DEATH DIS 2022 10.1038/s41419-022-04568-4 ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma Kim, JY; Bahar, E; Lee, JY; Chang, S; Kim, SH; Park, EY; Do, SI; Yoon, H; Kim, HS
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12030599 Local and Metastatic Relapses in a Young Woman with Papillary Squamous Cell Carcinoma of the Uterine Cervix Woo, HY; Kim, HS
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12030643 Extraskeletal Mesenchymal Chondrosarcoma of the Uterus Lee, Y; Choi, S; Kim, HS
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12030660 Dissecting Gonadoblastoma of the Ovary Coexistent with an Atypical Endometriotic Cyst: Incidental Detection in Cystectomy Specimen of a Woman with 46,XX Karyotype Jung, H; Yun, BS; Jung, YY; Kim, HS
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12020326 Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics Koh, HH; Park, E; Kim, HS
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12010119 Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation Lee, H; Kim, H; Kim, HS
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11112042 Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors Kim, H; Na, K; Bae, GE; Kim, HS
    View PubMed
  • IN VIVO 2021 10.21873/invivo.12667 Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma Kim, H; Bae, GE; Jung, YY; Kim, HS
    View PubMed
  • CANCER GENOM PROTEOM 2021 10.21873/cgp.20290 Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression Choi, S; Kim, SW; Kim, HS
    View PubMed
  • ANTICANCER RES 2021 10.21873/anticanres.15272 Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma Choi, KH; Kim, H; Bae, GE; Lee, SH; Woo, HA; Kim, HS
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11081450 Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma Park, S; Bae, GE; Kim, J; Kim, HS
    View PubMed
  • IN VIVO 2021 10.21873/invivo.12499 Clinicopathological Characteristics of Gastric-type Endocervical Adenocarcinoma Misdiagnosed as an Endometrial, Ovarian or Extragenital Malignancy, or Mistyped as Usual-type Endocervical Adenocarcinoma Koh, HH; Jung, YY; Kim, HS
    View PubMed
  • IN VIVO 2021 10.21873/invivo.12527 Clinicopathological Characteristics of Microscopic Tubal Intraepithelial Metastases from Adenocarcinoma and Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Lee, J; Park, S; Woo, HY; Kim, HS
    View PubMed
  • ANTICANCER RES 2021 10.21873/anticanres.15053 Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus Choi1, S; Na, K; Kim, SW; Kim, HS
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11040717 Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site TP53 Mutation Choi1, S; Jung, YY; Kim, HS
    View PubMed
  • INT J MOL SCI 2021 10.3390/ijms22083916 Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway Bahar1, E; Kim, JY; Kim, DC; Kim, HS; Yoon, H
    View PubMed
  • INT J SURG PATHOL 2021 10.1177/10668969211006194 Cardiophrenic Lymph Node Metastasis of Ovarian High-grade Serous Carcinoma Showing Wild-type p53 Immunostaining Pattern and Aberrant CD56 Expression Kwon1, HJ; Oh, M; Han, J; Song, SY; Kim, HS
    View PubMed
  • IN VIVO 2021 10.21873/invivo.12332 Diagnostic Utility of Oncomine Comprehensive Assay v3 in Differentiating Between Isocitrate Dehydrogenase (IDH)-mutated Grade II-III Astrocytoma and Oligodendroglioma Kim1, SW; Park, BJ; Kim, HS; Na, K
    View PubMed
  • ANTICANCER RES 2021 10.21873/anticanres.14918 Prominent Papillary Growth Pattern and Severe Nuclear Pleomorphism Induced by Neoadjuvant Chemotherapy in Ovarian Mucinous Carcinoma: Potential for Misdiagnosis as High-grade Serous Carcinoma Kwon1, HJ; Song, SY; Kim, HS
    View PubMed
  • EUR J GYNAECOL ONCOL 2021 10.31083/j.ejgo.2021.01.2209 Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy Noh1, JJ; Choi, KH; Kim, HS; Lee, JW
    View PubMed
  • TAIWAN J OBSTET GYNECOL 2021 10.1016/j.tjog.2020.11.020 Vulvar epithelioid sarcoma: A case report with literature review Noh1, JJ; Jeon, JE; Jung, H; Kim, HS; Lee, YY; Choi, CH; Lee, JW
    View PubMed
  • MOL ONCOL 2021 10.1002/1878-0261.12884 Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma Shin1, H; Yang, W; Chay, DB; Lee, EJ; Chung, JY; Kim, HS; Kim, JH
    View PubMed
  • CANCER GENOMICS PROTEOMICS 2020 10.21873/cgp.20235 Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRAS) and Gain of Chromosome 1q Kim1, H; Yoon, N; Woo, H; Lee, EJ; Do, SI; Na, K; Kim, HS
    View PubMed
  • J GYNECOL ONCOL 2020 10.3802/jgo.2020.31.e78 Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer Chang1, JS; Kim, N; Kim, JY; Do, SI; Cho, Y; Kim, HS; Kim, YB
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-77075-1 Clinical factors associated with prognosis in low-grade serous ovarian carcinoma experiences at two large academic institutions in Korea and Taiwan Kang1, JH; Lai, YL; Cheng, WF; Kim, HS; Kuo, KT; Chen, YL; Lee, YY
    View PubMed
  • CANCER GENOMICS PROTEOMICS 2020 10.21873/cgp.20234 Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas Yoon1, N; Kim, HS; Lee, JW; Lee, EJ; Maeng, LS; Yoon, WS
    View PubMed
  • CANCERS 2020 10.3390/cancers12113188 Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041) Choi1, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14594 Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 in Gallbladder Carcinoma Kim1, SJ; Kim, SW; Oh, CH; Hong, M; Do, SI; Kim, YW; Kim, HS; Na, K
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21207613 Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression Bahar1, E; Kim, JY; Kim, HS; Yoon, H
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14613 Characterization of Paired Box 8 (PAX8)-expressing Metastatic Breast Carcinoma Kim1, SW; Kim, HS; Na, K
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.506 Early Assessment of Response to Neoadjuvant Chemotherapy with F-18-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer Chung1, YS; Kim, YOO; Lee, JY; Kang, WJ; Nam, EJ; Kim, SOO; Kim, SW; Kim, YTE
    View PubMed
  • IN VIVO 2020 10.21873/invivo.12079 Clinicopathological Characteristics of Squamous Cell Carcinoma and High-grade Squamous Intraepithelial Lesions Involving Endocervical Polyps Park1, CK; Kim, YW; Koh, HH; Yoon, N; Bae, GE; Kim, HS
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.583515 Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor Kang1, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ
    View PubMed
  • CANCER GENOMICS PROTEOMICS 2020 10.21873/cgp.20219 Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix Jung1, H; Bae, GE; Kim, HM; Kim, HS
    View PubMed
  • DIAGNOSTICS 2020 10.3390/diagnostics10080580 Primary Retroperitoneal Mucinous Carcinoma with Carcinosarcomatous Mural Nodules A Case Report with Emphasis on Its Histological Features and Immunophenotype Park1, S; Kim, HS
    View PubMed
  • DIAGNOSTICS 2020 10.3390/diagnostics10080537 Ovarian Gynandroblastoma with a Juvenile Granulosa Cell Tumor Component in a Postmenopausal Woman Hwang1, S; Kim, BG; Song, SY; Kim, HS
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21165813 E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer Eoh1, KJ; Kim, HJ; Lee, JW; Kim, LK; Park, SA; Kim, HS; Kim, YT; Koo, PJ
    View PubMed
  • DIAGNOSTICS 2020 10.3390/diagnostics10080595 Clinicopathological Characteristics of Pleomorphic High-Grade Squamous Intraepithelial Lesion of the Uterine Cervix A Single-Institutional Series of 31 Cases Kim1, H; Choi, S; Do, SI; Lee, SH; Yoon, N; Kim, HS
    View PubMed
  • MODERN PATHOL 2020 10.1038/s41379-020-0614-0 Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix Park1, E; Kim, SW; Kim, S; Kim, HS; Lee, JY; Kim, YT; Cho, NH
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14334 Impact of Implementing the Paris System for Reporting Urinary Cytology: A Single-institutional Experience With Emphasis on Diagnostic Yield of High-grade Urothelial Carcinoma and Low-grade Urothelial Neoplasm Koh1, HH; Lee, MJ; Park, NJ; Kim, HS; Oh, YL
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14271 Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology Park1, S; Cho, EY; Oh, YL; Park, YH; Kim, HS
    View PubMed
  • INT J CANCER 2020 10.1002/ijc.32729 Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy Lee1, YJ; Kim, D; Shim, JE; Bae, SJ; Jung, YJ; Kim, S; Lee, H; Kim, SH; Jo, SB; Lee, JY; Kim, HS; Paik, S
    View PubMed
  • DIAGNOSTICS 2020 10.3390/diagnostics10030150 Endometrium-Limited Metastasis of Extragenital Malignancies: A Challenge in the Diagnosis of Endometrial Curettage Specimens Choi1, S; Joo, JW; Do, SI; Kim, HS
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14093 Clinicopathological and Prognostic Significance of Programmed Death Ligand 1 Expression in Korean Patients With Triple-negative Breast Carcinoma Kim1, HS; Do, SI; Kim, DH; Apple, S
    View PubMed

해당하는 결과가 없습니다.